Zydus Lifesciences per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹44.87₹50.09₹44.97₹38.14₹19.30
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹44.87₹50.09₹44.97₹38.14₹19.30
₹269.50₹269.50₹238.10₹197.11₹173.08
₹284.21₹269.86₹231.03₹194.31₹170.33
—₹21.04₹67.36₹32.09₹26.57
−₹12.70−₹12.70₹50.34₹23.07₹16.38
—₹11.00₹3.01₹6.17₹2.64
100.6100.6100.6100.6101.2
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ZYDUSLIFE₹1,175.50

Zydus Lifesciences Ltd.

· Pharma & Health
₹ CrorePeersSUNPHARMADRREDDYCIPLATORNTPHARMDIVISLABMAXHEALTHAPOLLOHOSPAUROPHARMAMcap ₹1.18L Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS19.3038.1444.9750.0944.87
Diluted EPS19.3038.1444.9750.0944.87
Book Value per Share173.08197.11238.10269.50269.50
Revenue per Share170.33194.31231.03269.86284.21
Cash Flow per Share26.5732.0967.3621.04—
Free Cash Flow per Share16.3823.0750.34-12.70-12.70
Dividends per Share2.646.173.0111.00—
Shares Outstanding (cr)101.2100.6100.6100.6100.6
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.